Literature DB >> 25572397

Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.

Kaushik Dutta1, Avanish K Varshney2, Matthew C Franklin3, Michael Goger3, Xiaobo Wang4, Bettina C Fries5.   

Abstract

Staphylococcal enterotoxin B (SEB) is a superantigen that cross-links the major histocompatibility complex class II and specific V-β chains of the T-cell receptor, thus forming a ternary complex. Developing neutralizing mAb to disrupt the ternary complex and abrogate the resulting toxicity is a major therapeutic challenge because SEB is effective at very low concentrations. We show that combining two SEB-specific mAbs enhances their efficacy, even though one of the two mAbs by itself has no effect on neutralization. Crystallography was employed for fine-mapping conformational epitopes in binary and ternary complexes between SEB and Fab fragments. NMR spectroscopy was used to validate and identify subtle allosteric changes induced by mAbs binding to SEB. The mapping of epitopes established that a combination of different mAbs can enhance efficacy of mAb-mediated protection from SEB induced lethal shock by two different mechanisms: one mAb mixture promoted clearance of the toxin both in vitro and in vivo by FcR-mediated cross-linking and clearance, whereas the other mAb mixture induced subtle allosteric conformational changes in SEB that perturbed formation of the SEB·T-cell receptor·major histocompatibility complex class II trimer. Finally structural information accurately predicted mAb binding to other superantigens that share conformational epitopes with SEB. Fine mapping of conformational epitopes is a powerful tool to establish the mechanism and optimize the action of synergistic mAb combinations.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Bacterial Toxin; Crystal Structure; Epitope Mapping; Monoclonal Antibody; Nuclear Magnetic Resonance (NMR); SEB; Staphylococcal Enterotoxin B; X-ray Crystallography

Mesh:

Substances:

Year:  2015        PMID: 25572397      PMCID: PMC4358096          DOI: 10.1074/jbc.M114.630715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

2.  Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.

Authors:  A C Papageorgiou; H S Tranter; K R Acharya
Journal:  J Mol Biol       Date:  1998-03-20       Impact factor: 5.469

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  A novel strategy for NMR resonance assignment and protein structure determination.

Authors:  Alexander Lemak; Aleksandras Gutmanas; Seth Chitayat; Murthy Karra; Christophe Farès; Maria Sunnerhagen; Cheryl H Arrowsmith
Journal:  J Biomol NMR       Date:  2010-12-14       Impact factor: 2.835

5.  Unraveling the allosteric mechanism of serine protease inhibition by an antibody.

Authors:  Rajkumar Ganesan; Charles Eigenbrot; Yan Wu; Wei-Ching Liang; Steven Shia; Michael T Lipari; Daniel Kirchhofer
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

6.  Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro.

Authors:  Joanne M O'Hara; Nicholas J Mantis
Journal:  J Immunol Methods       Date:  2013-06-15       Impact factor: 2.303

7.  Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.

Authors:  James Pettitt; Larry Zeitlin; Do H Kim; Cara Working; Joshua C Johnson; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael H Pauly; Kevin J Whaley; Michael F Ingram; Ashley Zovanyi; Megan Heinrich; Ashley Piper; Justine Zelko; Gene G Olinger
Journal:  Sci Transl Med       Date:  2013-08-21       Impact factor: 17.956

8.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

Authors:  J A Mollick; G G Miller; J M Musser; R G Cook; D Grossman; R R Rich
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Isolation and culture of murine macrophages.

Authors:  John Q Davies; Siamon Gordon
Journal:  Methods Mol Biol       Date:  2005

10.  Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.

Authors:  A R Hamad; A Herman; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  20 in total

Review 1.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

2.  Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Authors:  Yuanyuan Liu; Zhen Song; Shuang Ge; Jinyong Zhang; Limin Xu; Feng Yang; Dongshui Lu; Ping Luo; Jiang Gu; Quanming Zou; Hao Zeng
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

Review 3.  Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.

Authors:  William E Sause; Peter T Buckley; William R Strohl; A Simon Lynch; Victor J Torres
Journal:  Trends Pharmacol Sci       Date:  2015-12-22       Impact factor: 14.819

4.  Engineering therapeutic antibodies to combat infectious diseases.

Authors:  Ellen K Wagner; Jennifer A Maynard
Journal:  Curr Opin Chem Eng       Date:  2018-03-07       Impact factor: 5.163

5.  Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.

Authors:  Jorge L Aguilar; Avanish K Varshney; Ximo Pechuan; Kaushik Dutta; Joshua D Nosanchuk; Bettina C Fries
Journal:  Virulence       Date:  2016-10-07       Impact factor: 5.882

Review 6.  An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.

Authors:  Arijit Ghosh; Paritosh K Kar; Anupam Gautam; Rahul Gupta; Rajveer Singh; Rudra Chakravarti; Velayutham Ravichandiran; Shubhra Ghosh Dastidar; Dipanjan Ghosh; Syamal Roy
Journal:  RSC Med Chem       Date:  2022-01-25

Review 7.  Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Authors:  Cuong Vuong; Anthony J Yeh; Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Investig Drugs       Date:  2015-11-04       Impact factor: 6.206

8.  Engineered pH-dependent recycling antibodies enhance elimination of Staphylococcal enterotoxin B superantigen in mice.

Authors:  Andrew Kroetsch; Chunxia Qiao; Mairead Heavey; Leiming Guo; Dhaval K Shah; Sheldon Park
Journal:  MAbs       Date:  2018-12-11       Impact factor: 5.857

Review 9.  Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy.

Authors:  Cin Kong; Hui-min Neoh; Sheila Nathan
Journal:  Toxins (Basel)       Date:  2016-03-15       Impact factor: 4.546

10.  Bactericidal fully human single-chain fragment variable antibodies protect mice against methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Behnoush Soltanmohammadi; Somayeh Piri-Gavgani; Eilnaz Basardeh; Mostafa Ghanei; Masoumeh Azizi; Zabihollah Khaksar; Zahra Sharifzadeh; Farzad Badmasti; Mahdieh Soezi; Abolfazl Fateh; Parisa Azimi; Seyed Davar Siadat; Fahimeh Shooraj; Saeid Bouzari; Mir Davood Omrani; Fatemeh Rahimi-Jamnani
Journal:  Clin Transl Immunology       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.